News
Nippon Kayaku's news releases are issued to inform our stakeholders of the latest information regarding the Company.
While some news releases may contain information about pharmaceutical products (including those under development), they are intended solely for disclosure purposes to members of the media, shareholders, and investors, and are not intended for advertising or promotional purposes, nor to provide medical advice.
- 2022/11/16
-
Launch in Japan of Bevacizumab BS for I.V. Infusion 100mg・400mg “CTNK” ,an anti-VEGF humanized monoclonal antibody
- 2021/06/30
-
New Late-Breaking Data at The American Diabetes Association Show GlycoMark May Be an Effective Test for COVID-19 Severity
- 2020/07/06
-
Pict Leap Co., Ltd has developed “ Liquid Crystal Display Which Can Be Photographed By Infrared Camera ”
- 2020/02/07
-
Pict Leap Co., Ltd has developed "32-inch off-grid outdoor display system


